PCRX - Pacira Pharmaceuticals Net earnings per share (EPS TTM)
Pacira BioSciences (PCRX) is developing a non-opioid pain management system through its drug EXPAREL, integrating it into hospital protocols. However, new long-acting anesthetics pose a risk, threatening current contracts. A stable staff of R&D specialists supports business growth. The trailing 12-month EPS reflects net income dynamics, with the current level standing at 0.92.
Comprehensive metric breakdowns and analytics for Pacira Pharmaceuticals (PCRX)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
- net income and valuation multiples indicators:
PCRX - Final Profit|Projected Future Earnings Pacira BioSciences|PCRX - P/E Multiple|Projected Price to Earnings Pacira BioSciences, Inc.|PCRX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Pacira BioSciences, Inc.|PCRX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Pacira BioSciences|PCRX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months pacira.com|PCRX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Pacira BioSciences
Analysis of all company metrics:Pacira BioSciences (PCRX)
Rising demand for non-opioid anesthesia in the outpatient segment drives the scaling potential of Pacira BioSciences (PCRX), establishing net income per share as the primary metric for capital allocation efficiency. By analyzing the change in per-share profit over the last 12 months, investors assess the total financial result adjusted for share dilution, which reveals the actual resilience of the business's cash flows regardless of quarterly fluctuations.
Competitor analysis
HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia LQDA|GLPG (Galapagos N.V.) - Earnings per one share for the last 12 months|ANI Pharma - Net earnings per share (EPS TTM)|MNKD - Net earnings per share (EPS TTM)|AMPH: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ars-pharma.com|TBPH (Theravance Biopharma, Inc.) - Net earnings per share (EPS TTM)|Aquestive Therapeutics Inc (AQST) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TNXP (Tonix Pharmaceuticals)|Net earnings per share (EPS TTM) SXT Pharmaceuticals SXTC|EPRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year BHST (BioHarvest Sciences, Inc.)|EXOZ: Net earnings per share (EPS TTM)|ORMP (Oramed Pharmaceuticals Inc.) - Earnings per share for the last twelve months|ENTX (Entera Bio Ltd) - Net earnings per share (EPS TTM)|ipatherapeutics.com (HYFT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months ABVC BioPharma, Inc. (ABVC)|CPIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Quantum BioPharma Limited QNTM|Net earnings per share for the last four quarters FibroGen Corporation (FGEN)|Telomir Pharmaceuticals - Net earnings per share (EPS TTM)|Rani Therapeutics (RANI) - Net earnings per share for the last 12 months|SNYR: Net earnings per share (EPS TTM)|RLYB - Net earnings per share for the last four quarters|LEXX (Lexaria Bioscience Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pulmatrix Corporation PULM|Earnings per share for the last twelve months Pheton Holdings Ltd (PTHL)|aptorumgroup.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics)|IBO - Net earnings per share for the last 12 months|TNF Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months cbdMD, Inc.|PainReform Ltd. (PRFX) - Earnings per share for the last twelve months|CYTO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Lipella Pharmaceuticals, Inc.|OptiNose Inc - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PIRS|Net earnings per share for the last 12 months Procaps Group Corp PROC|Earnings per share for the last twelve months Petros Pharmaceuticals PTPI|Earnings per share for the trailing year QLI|SLRN: Net earnings per share for the last 12 months|TFFP (TFF Pharmaceuticals Inc.) - Earnings per share for the last 12 months
